VOYA Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-24,252
Closed -$3.67M 2991
2022
Q3
$3.67M Buy
24,252
+693
+3% +$105K ﹤0.01% 1075
2022
Q2
$3.43M Sell
23,559
-46,743
-66% -$6.81M 0.01% 890
2022
Q1
$8.34M Buy
70,302
+20,898
+42% +$2.48M 0.02% 683
2021
Q4
$6.81M Sell
49,404
-82,875
-63% -$11.4M 0.01% 733
2021
Q3
$18.4M Sell
132,279
-50,588
-28% -$7.03M 0.04% 358
2021
Q2
$17.8M Sell
182,867
-27,273
-13% -$2.65M 0.03% 388
2021
Q1
$14.4M Buy
210,140
+29,097
+16% +$1.99M 0.03% 453
2020
Q4
$15.5M Sell
181,043
-24,395
-12% -$2.09M 0.03% 415
2020
Q3
$13.4M Sell
205,438
-2,024
-1% -$132K 0.03% 440
2020
Q2
$15.2M Sell
207,462
-87,196
-30% -$6.37M 0.04% 406
2020
Q1
$10M Buy
294,658
+20,110
+7% +$684K 0.03% 485
2019
Q4
$14.9M Sell
274,548
-139,032
-34% -$7.57M 0.03% 479
2019
Q3
$17.3M Buy
413,580
+157,079
+61% +$6.55M 0.04% 429
2019
Q2
$11.2M Buy
256,501
+244,175
+1,981% +$10.7M 0.02% 570
2019
Q1
$634K Buy
12,326
+351
+3% +$18.1K ﹤0.01% 1637
2018
Q4
$443K Sell
11,975
-260
-2% -$9.62K ﹤0.01% 1802
2018
Q3
$459K Sell
12,235
-620
-5% -$23.3K ﹤0.01% 1890
2018
Q2
$508K Sell
12,855
-602
-4% -$23.8K ﹤0.01% 1821
2018
Q1
$347K Buy
+13,457
New +$347K ﹤0.01% 2022